TranS1 was granted patents addressing presacral interbody fusion technologies, including two new expandable cages designed to create lordosis at L5-S1 and a new sacroiliac fusion technique.
In all, the company has >100 issued patents and has filed >50 applications in the last three years.
The TranS1 portfolio comprises minimally invasive approaches with the Pylon™ system for posterolateral decortication and bone graft placement, KeyLIF™ MIS Oblique Lateral Interbody Fusion system and AxiaLIF® presacral interbody fusion.
Soruce: TranS1
TranS1 was granted patents addressing presacral interbody fusion technologies, including two new expandable cages designed to create lordosis at L5-S1 and a new sacroiliac fusion technique.
In all, the company has >100 issued patents and has filed >50 applications in the last three years.
The TranS1 portfolio comprises minimally...
TranS1 was granted patents addressing presacral interbody fusion technologies, including two new expandable cages designed to create lordosis at L5-S1 and a new sacroiliac fusion technique.
In all, the company has >100 issued patents and has filed >50 applications in the last three years.
The TranS1 portfolio comprises minimally invasive approaches with the Pylon™ system for posterolateral decortication and bone graft placement, KeyLIF™ MIS Oblique Lateral Interbody Fusion system and AxiaLIF® presacral interbody fusion.
Soruce: TranS1
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.